Amphetamine dependence and co-morbid alcohol abuse: Associations to brain cortical thickness

BMC Pharmacology

Volumn 10, Issue , 2010, Pages

  Lawyer, Glenn ^a,b   Bjerkan, Petr S ^a   Hammarberg, Anders ^c   Jayaram Lindström, Nitya ^c   Franck, Johan ^c   Agartz, Ingrid ^a,c,d  

^a UNIVERSITY OF OSLO   (Norway)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BRAIN CORTEX; BRAIN CORTICAL THICKNESS; CLINICAL ARTICLE; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG DEPENDENCE; GRAY MATTER; HUMAN; LEFT HEMISPHERE; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RIGHT HEMISPHERE; THICKNESS; ADULT; ALCOHOLISM; BRAIN INJURY; DRUG ABUSE; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; SUBSTANCE ABUSE; URINE;

ADULT; ALCOHOLISM; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; COMORBIDITY; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 77952369615     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-10-5     Document Type: Article

References (54)

1. European Monitoring Centre for Drugs and Drug Addiction Annual report: the state of the drugs problem in Europe 2008, Luxembourg: Office for Official Publications of the European Communities, European Monitoring Centre for Drugs and Drug Addiction.
2. Kao CH, Wang SJ, Yeh SH. Presentation of regional cerebral blood flow in amphetamine abusers by 99Tcm-HMPAO brain SPECT. Nuclear medicine communications 1994, 15(2):94-98. 10.1097/00006231-199402000-00005, 8170643.
3. Iyo M, Namba H, Yanagisawa M, Hirai S, Yui N, Fukui S. Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT. Progress in Neuropsychopharmacology and Biological psychiatry 1997, 21(5):789-796. 10.1016/S0278-5846(97)00079-1.
4. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Research 2002, 114(2):65-79. 10.1016/S0925-4927(02)00004-5, 12036507.
5. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 2002, 26:53-63. 10.1016/S0893-133X(01)00334-7, 11751032.
6. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. The Journal of neuroscience 1998, 18(20):8417-8422. 9763484.
7. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. The American journal of psychiatry 2001, 158(8):1206-1214. 10.1176/appi.ajp.158.8.1206, 11481152.
8. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. The Journal of neuroscience 2001, 21(23):9414-9418. 11717374.
9. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. The American journal of psychiatry 2003, 160(9):1699-1701. 10.1176/appi.ajp.160.9.1699, 12944350.
10. Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 2000, 54(6):1344-1349. 10746608.
11. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. The American journal of psychiatry 2001, 158(12):2015-2021. 10.1176/appi.ajp.158.12.2015, 11729018.
12. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of general psychiatry 2004, 61:73-84. 10.1001/archpsyc.61.1.73, 14706946.
13. Berman S, O'Neill J, Fears S, Bartzokis G, London ED. Abuse of amphetamines and structural abnormalities in the brain. Annals of the New York Academy of Sciences 2008, 1141:195-220. 10.1196/annals.1441.031, 2769923, 18991959.
14. Alicata D, Chang L, Cloak C, Abe K, Ernst T. Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res 2009, 174:1-8. 10.1016/j.pscychresns.2009.03.011, 19782540.
15. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiology of aging 2000, 21(2):331-342. 10.1016/S0197-4580(00)00111-1, 10867218.
16. McMurtray A, Nakamoto B, Shikuma C, Valcour V. Cortical atrophy and white matter hyperintensities in HIV: the Hawaii Aging with HIV Cohort Study. Journal of stroke and cerebrovascular diseases 2008, 17(4):212-217. 10.1016/j.jstrokecerebrovasdis.2008.02.005, 2525800, 18589342.
17. Hoffman WF, Schwartz DL, Huckans MS, McFarland BH, Meiri G, Stevens AA, Mitchell SH. Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) 2008, 201(2):183-193. 10.1007/s00213-008-1261-1, 2835463, 18685833.
18. Salo R, Ursu S, Buonocore MH, Leamon MH, Carter C. Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study. Biol Psychiatry 2009, 65(8):706-709. 10.1016/j.biopsych.2008.11.026, 2678684, 19136097.
19. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. The Journal of neuroscience 2004, 24(26):6028-6036. 10.1523/JNEUROSCI.0713-04.2004, 15229250.
20. Kim SJ, Lyoo IK, Hwang J, Chung A, Sung YH, Kim J, Kwon DH, Chang KH, Renshaw PF. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. The International Journal of Neuropsychopharmacology 2006, 9(2):221-228. 10.1017/S1461145705005699, 15982446.
21. Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Research 2000, 98(2):93-102. 10.1016/S0925-4927(99)00052-9, 10762735.
22. Schlaepfer TE, Lancaster E, Heidbreder R, Strain EC, Kosel M, Fisch HU, Pearlson GD. Decreased frontal white-matter volume in chronic substance abuse. The International Journal of Neuropsychopharmacology 2006, 9(2):147-153. 10.1017/S1461145705005705, 16004619.
23. Jayaram-Lindström N, Hammarberg A, Beck O, Franck J. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. The American journal of psychiatry 2008, 165(11):1442-1448. 10.1176/appi.ajp.2008.08020304, 18765480.
24. Darke S, Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug and alcohol dependence 1995, 39(3):231-235. 10.1016/0376-8716(95)01171-9, 8556972.
25. Fein G, Di Sclafani V, Cardenas V, Goldmann H, Tolou-Shams M, Meyerhoff D. Cortical gray matter loss in treatment-naïve alcohol dependent individuals. Alcoholism, clinical and experimental research 2002, 26(4):558-564. 2435064, 11981133.
26. Kril J, Halliday G, Svoboda M, Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997, 79(4):983-998. 10.1016/S0306-4522(97)00083-3, 9219961.
27. Pfefferbaum A, Sullivan E, Mathalon D, Lim K. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcoholism, clinical and experimental research 1997, 21(3):521-529. 9161613.
28. Pfefferbaum A, Sullivan E, Rosenbloom M, Mathalon D, Lim K. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Archives of general psychiatry 1998, 55(10):905-912. 10.1001/archpsyc.55.10.905, 9783561.
29. Gazdzinski S, Durazzo TC, Studholme C, Song E, Banys P, Meyerhoff DJ. Quantitative brain MRI in alcohol dependence: preliminary evidence for effects of concurrent chronic cigarette smoking on regional brain volumes. Alcoholism, clinical and experimental research 2005, 29(8):1484-1495. 10.1097/01.alc.0000175018.72488.61, 16131857.
30. Weissenborn K, Tryc AB, Heeren M, Worthmann H, Pflugrad H, Berding G, Bokemeyer M, Tillmann HL, Goldbecker A. Hepatitis C virus infection and the brain. Metab Brain Dis 2009, 24:197-210. 10.1007/s11011-008-9130-5, 19130196.
31. Martin-Thormeyer EM, Paul RH. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev 2009, 19(2):215-231. 10.1007/s11065-009-9101-6, 19468837.
32. Hall H, McNeil T, Arnborg S, Agartz I, Ösby U, Linder J, Sedvall G. HUBIN - Human Brain Informatics: A clinical database project for multidisciplinary research in schizophrenia. European psychiatry 2000, 15(suppl 2):299s.
33. Arnborg S, Agartz I, Nordström M, Hall H, Sedvall G. Human Brain Informatics - understanding causes of mental illness. ERCIM News 2000, 3:24-25.
34. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. Journal of substance abuse treatment 1992, 9(3):199-213. 10.1016/0740-5472(92)90062-S, 1334156.
35. Sobell L, Sobell MB. chap. Timeline Follow-back: A technique for assessing self-reported ethanol consumption. Measuring alcohol consumption: Psycosocial and biological methods 1992, 44-72. New Jersey: Humana Press, Allen J, Litten RZ.
36. Spitzer R, Williams J, Gibbon M. Structured Clinical Interview for DSM-III-R- Non-patient Version (SCID-NP) 1986, Biometrics Research Department, New York State Psychiatric Institute, New York, USA.
37. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-III-R- Patient Version (SCID-P) 1988, Biometrics Research Department, New York State Psychiatric Institute, New York, USA.
38. Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993, 88(6):791-804. 10.1111/j.1360-0443.1993.tb02093.x, 8329970.
39. Conigrave K, Hall W, Saunders J. The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction 1995, 90(10):1349-1356. 10.1111/j.1360-0443.1995.tb03552.x, 8616463.
40. Dale A, Fischl B, Sereno M. Cortical surface-based analysis - I: Segmentation and surface reconstruction. NeuroImage 1999, 9(2):179-194. 10.1006/nimg.1998.0395, 9931268.
41. Fischl B, Sereno M, Dale A. Cortical surface-based analysis - II: Inflation, flattening, and a surface-based coordinate system. NeuroImage 1999, 9(2):195-207. 10.1006/nimg.1998.0396, 9931269.
42. Fischl B, Sereno MI, Tootell RB, Dale AM. High-resolution intersubject averaging and a coordinate system for the cortical surface. Human Brain Mapping 1999, 8(4):272-284. 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4, 10619420.
43. Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE transactions on medical imaging 2001, 20:70-80. 10.1109/42.906426, 11293693.
44. Ségonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B. A hybrid approach to the skull stripping problem in MRI. NeuroImage 2004, 22(3):1060-1075. 10.1016/j.neuroimage.2004.03.032, 15219578.
45. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE transactions on medical imaging 1998, 17:87-97. 10.1109/42.668698, 9617910.
46. S'egonne F, Pacheco J, Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE transactions on medical imaging 2007, 26(4):518-529. 10.1109/TMI.2006.887364, 17427739.
47. Dale A, Sereno M. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. Journal of cognitive neuroscience 1993, 5:162-176.
48. Fischl B, Dale A. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the USA 2000, 97:11044-11049. 10.1073/pnas.200033797, 27145, 10995460.
49. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, Kouwe A, Jenkins BG, Dale AM, Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002, 58(5):695-701.
50. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, Goff D, West WC, Williams SCR, Kouwe AJW, Salat DH, Dale AM, Fischl B. Regionally localized thinning of the cerebral cortex in schizophrenia. Archives of general psychiatry 2003, 60(9):878-888. 10.1001/archpsyc.60.9.878, 12963669.
51. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RSR, Busa E, Morris JC, Dale AM, Fischl B. Thinning of the cerebral cortex in aging. Cerebral cortex 2004, 14(7):721-730. 10.1093/cercor/bhh032, 15054051.
52. Han X, Jovicich J, Salat D, Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 2006, 32:180-194. 10.1016/j.neuroimage.2006.02.051, 16651008.
53. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B 1995, 57:289-300.
54. Genovese C, Lazar N, Nichols T. Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate. NeuroImage 2002, 15(4):870-878. 10.1006/nimg.2001.1037, 11906227.